Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 752.50
-9.50 (-1.25%)
Mar 6, 2026, 1:44 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 19.70 million as of March 6, 2026. Its market cap has decreased by -68.55% in one year.
Market Cap
19.70M
Enterprise Value
-1.75M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
752.50
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 19.70M, a decrease of -71.66%. That is a compound annual growth rate of -7.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 20.82M |
| Purple Biotech | 18.58M |
| Evogene | 21.42M |
| BioLight Life Sciences | 31.31M |
| BioLineRx | 39.16M |
| Clal Biotechnology Industries | 46.43M |
| Matricelf | 146.87M |
| Geffen Residence & Renewal | 277.04M |